Mobile-based obstetric monitoring for hypertension and diabetes during pregnancy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial tests a mobile-based perinatal telemonitoring program (MOM-HD) plus standard care versus standard care alone in pregnant individuals with hypertensive disorders or gestational diabetes in Nepal. It uses a hybrid Type II effectiveness-implementation randomized design to measure clinical outcomes and how well the program can be implemented in real-world settings. The program includes a patient app for uploading measurements, a provider web portal, and biweekly tele-visit support, with training, financial assistance for devices, and institutional advisory structures. Implementation outcomes are examined across patients, providers, and health systems using established frameworks. The study targets multiple centers in Nepal to assess generalizability and feasibility in real-world maternity care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Pregnant women receiving antenatal care at RCT site
* Diagnosed with one of the following:

  * Chronic hypertension (sustained systolic BP ≥140 mm Hg and/or diastolic BP ≥90 mm Hg, or on antihypertensive treatment before 20 weeks of gestation)
  * Gestational hypertension or preeclampsia without severe features (sustained systolic BP ≥140 mm Hg and/or diastolic BP ≥90 mm Hg after 20 weeks of gestation)
  * Gestational diabetes
* Age 18 years or older
* Access to a smartphone
* Gestational age ≤ 34 weeks at enrollment
* Able to read and write

Exclusion Criteria:

* Multifetal pregnancies
* Apparent communication difficulties (e.g., hearing, speech, or cognitive impairments), as judged by research assistants
* Unable to understand the Nepali language
* Severe maternal illness or any condition that precludes active study participation (e.g., preeclampsia with severe features, eclampsia, HELLP syndrome, or other conditions requiring inpatient management)
* Declines to provide informed consent

Where it's running

• Nobel Medical College & Teaching Hospital
  Biratnagar, Nepal Recruiting
• Dhulikhel Hospital
  Dhulikhel, Nepal Recruiting
• Paropakar Maternity and Women's Hospital
  Kathmandu, Nepal Recruiting

Study contacts

• Principal investigator: Shristi Rawal, PhD — Rutgers School of Health Professions
• Study coordinator: Shristi Rawal, PhD
• Email: shristi.rawal@rutgers.edu
• Phone: +18606908495

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Early Glucose Patterns in Pregnant Women at Risk for GDM

  This study tests whether continuous glucose monitoring in early pregnancy can detect dysglycemia before GDM is diagnosed, in women with and without known risk factors.

  Recruiting DCB Research AG · Bern, Canton of Bern · NCT07783178

• Endothelial Biomarkers in Pregnancy: Endothelial Extracellular Vesicles and Hypertensive Disorders

  This study tests whether endothelial extracellular vesicles in the blood differ between normotensive pregnant women and those with hypertensive disorders of pregnancy.

  Recruiting Josip Juraj Strossmayer University of Osijek · Osijek · NCT07728656

• Enhanced support for Connected MOM Plus in pregnancy and postpartum care

  A program that tests whether extra coaching helps pregnant people use Connected MOM Plus more, especially if they have limited access to care.

  Recruiting Tulane University · New Orleans, Louisiana · NCT07691541

• Probiotic-augmented therapy for gestational diabetes

  This trial tests whether adding multistrain probiotics to metformin, insulin, or their combination can improve blood sugar control and inflammation in pregnant women with gestational diabetes.

  Recruiting Riphah International University · Rawalpindi, Punjab Province · NCT07645001

• Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes

  This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.

  Recruiting University of Tennessee Graduate School of Medicine · Knoxville, Tennessee · NCT07565727

• Progesterone to Prevent Preeclampsia in Early Pregnancy

  This trial tests whether nightly vaginal progesterone started before 12 weeks can lower the chance of preeclampsia in low-risk pregnant people.

  Recruiting Phase 4 Medical University of South Carolina · Charleston, South Carolina · NCT07448597

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.